A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: Regulation of COX-2 by butyrate

Carcinogenesis

Volumn 21, Issue 1, 2000, Pages 69-77

  Crew, Tracey E ^a   Elder, Douglas J E ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADENOMA; ARTICLE; CANCER PREVENTION; CELL STRAIN HT29; CHEMOPROPHYLAXIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIETARY FIBER; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTYRATES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033957363     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.1.69     Document Type: Article

References (54)

1. Burkitt, D.P. (1971) Epidemiology of cancer of the colon and rectum. Cancer, 28, 3-13.
2. Howe, G.R., Benito, E., Castelleto, R., Cornee, J., Esteve, J., Gallagher, R.P., Iscovich, J.M., Jiao, D.A., Kaaks, R., Kune, G.A., Kune, S., L'Abbe, K.A., Lee, H.P., Lee, M., Miller, A.B., Peters, R.K., Potter, J.D., Riboli, E., Slattery, M.L., Trichopoulos, D., Tuyns, A., Tzonou, A., Whittemore, A-S., Wu-Williams, A.H. and Shu, Z. (1992) Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J. Natl Cancer Inst., 84, 1887-1896.
3. Silvester, K.R., Englyst, H.N. and Cummings, J.H. (1995) Ileal recovery of starch from whole diets containing resistant starch measured in vitro and fermentation of ileal effluent. Am. J. Clin. Nutr., 62, 403-411.
4. Cummings, J.H. (1981) Short chain fatty acids in the human colon. Gut, 22, 763-779.
5. Hague, A., Manning, A.M., Hanlon, K.A., Huschtscha, L.I., Hart, D. and Paraskeva, C. (1993) Sodium bulyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int. J. Cancer, 55, 498-505.
6. Hague, A., Elder, D.J.E., Hicks, D.J. and Paraskeva, C. (1995) Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer, 60, 400-406.
7. Heerdt, B.G., Houston, M.A. and Augenlicht, L.H. (1994) Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res., 54, 3288-3294.
8. Caderni, G., Luceri, C., Lancioni, L., Tessitore, L. and Dolara, P. (1998) Slow-release pellets of sodium butyrate increase apoptosis in the colon of rats treated with azoxymethane, without affecting aberrant crypt foci and colonic proliferation. Nutr. Cancer, 30, 175-181.
9. Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G-M., Bartram, P., Christl, S., Richter, R, Dusel, G. and Kasper, H. (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology, 103, 51-56.
10. D'Argenio, G., Cosenza, V., Cave, M.D., Iovino, P., Valle, N.D., Lombardi, G. and Mazzacca, G. (1996) Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology, 110, 1727-1734.
11. Bonnotte, B., Favre, N., Reveneau, S., Micheau, O., Droin, N., Garrido, C., Fontana, A., Chauffert, B., Solary, E. and Martin, F. (1998) Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Differ., 5, 480-487.
12. Shiff, S.J. and Rigas, B. (1997) Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology, 113, 1992-1998.
13. Elder, D.J.E. and Paraskeva, C. (1999) Induced apoptosis in the prevention of colorectal cancer by non-steroidal anti-inflammatory drugs. Apoptosis, 4, 365-372.
14. Williams, C.S., Smalley, W. and Dubois, R.N. (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest., 100, 1325-1329.
15. Subbaramaiah, K., Zakim, D., Weksler, B.B. and Dannenberg, A.J. (1997) Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216, 201-210.
16. Kujubu, D.A., Fletcher, B.S., Varnum, B.C., Lim, R.W. and Herschman, H.R. (1991) TIS10, a phorbol ester tumour promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872.
17. O'Banion, M.K., Sadowski, H.B., Winn, V. and Young, D.A. (1991) A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol. Chem., 266, 23261-23267.
18. Dubois, R.N., Awad, J., Morrow, J., Roberts, L.J. and Bishop, P.R. (1994) Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93, 493-498.
19. Jones, D.A., Carlton, D.P., McIntyre, T.M., Zimmerman, G.A. and Prescott, S.M. (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem., 268, 9049-9054.
20. Xie, W. and Herschman, H.R. (1995) v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem., 270, 27622-27628.
21. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and Dubois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
22. Hao, X., Bishop, A.E., Wallace, M., Wang, H., Willcocks, J.C., Maclouf, J., Polak, J.M., Knight, S. and Talbot, I.C. (1999) Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J. Pathol., 187, 295-301.
23. Kargman, S.L., O'Neill, G.P., Vickers, P.J., Evans, J.F., Mancini, J.A. and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559.
24. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
25. 2. Gut, 35, 675-678.
26. Qiao, L., Kozoni, V., Tsioulias, G.J., Koutsos, M.I., Hanif, R., Shiff, S.J. and Rigas, B. (1995) Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258, 215-223.
27. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell, 87, 803-809.
28. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S. and Otomo, S. (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59.
29. Kawamori, T., Rao, C.V., Seibert, K. and Reddy, B.S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412.
30. Tsujii, M. and Dubois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
31. Fogh, J. and Trempe, G. (1975) New human tumour cell lines. In Fogh, J. (ed.) Human Tumour Cells In Vitro. Plenum Press, New York, NY, pp. 115-141.
32. Paraskeva, C., Buckle, B.G., Sheer, D. and Wigley, C.B. (1984) The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int. J. Cancer, 34, 49-56.
33. Williams, A.C., Harper, S.J. and Paraskeva, C. (1990) Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res., 50, 4724-4730.
34. Elder, D.J.E., Hague, A., Hicks, D.J. and Paraskeva, C. (1996) Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56, 2273-2276.
35. 2 in human colon cancer cells. Cancer Res., 58, 362-366.
36. Gregory, C.D., Dive, C., Henderson, S., Smith, C.A., Williams, G.T., Gordon, J. and Rickinson, A.B. (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature, 349, 612-614.
37. Kirkland, S.C. (1985) Dome formation by a human colonic adenocarcinoma cell line (HCA-7). Cancer Res., 45, 3790-3795.
38. Sheng, H., Shao, J., Kirkland, S.C., Isakson, P., Coffey, R.J., Morrow, J., Beauchamp, R.D. and Dubois, R.N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99, 2254-2259.
39. Elder, D.J.E., Halton, D.E., Hague, A. and Paraskeva, C. (1997) Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res., 3, 1679-1683.
40. Otto, J.C., DeWitt, D.L. and Smith, W.L. (1993) N-Glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem., 268, 18234-18242.
41. Coffey, R.J., Hawkey, C.J., Damstrup, L., Graves-Deal, R., Daniel, V.C., Dempsey, P.J., Chinery, R., Kirkland, S.C., Dubois, R.N., Jetton, T.L. and Morrow, J.D. (1997) Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc. Natl Acad. Sci. USA, 94, 657-662.
42. Kamitani, H., Geller, M. and Eling, T. (1998) Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J. Biol. Chem., 273, 21569-21577.
43. Bursch, W., Paffe, S., Putz, B., Barthel, G. and Schulte-Hermann, R. (1990) Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis, 11, 847-853.
44. L expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis. Radiat. Res., 149, 187-194.
45. Suganuma, M., Okabe, S., Kai, Y., Sueoka, N., Sueoka, E. and Fujiki, H. (1999) Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res., 59, 44-47.
46. Souleimani, A. and Asselin, C. (1993) Regulation of c-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2. Biochem. Biophys. Res. Commun., 193, 330-336.
47. Velazquez, O.C., Zhou, D.Y., Seto, R.W., Jabbar, A., Choi, J., Lederer, H.M. and Rombeau, J.L. (1996) In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-Fos and c-Jun expression. J. Parenter. Enteral Nutr., 20, 243-250 and 428.
48. Subbaramaiah, K., Chung, W.J. and Dannenberg, A.J. (1998) Ceramide regulates the transcription of cyclooxygenase-2: evidence for involvement of extracellular signal-regulated kinase/c-jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J. Biol. Chem., 273, 32943-32949.
49. Elder, D.J.E., Halton, D.E., Crew, T.E. and Paraskeva, C. (1999) Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int. J. Cancer, in press.
50. Lu, X., Xie, W., Reed, D., Bradshaw, W.S. and Simmons, D.L. (1995) Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl Acad. Sci. USA, 92, 7961-7965.
51. Sheng, H., Shao, J., Hooton, E.B., Tsujii, M., Dubois, R.N. and Beauchamp, R.D. (1997) Cyclooxygenase-2 induction and transforming growth factor β growth inhibition in rat intestinal epithelial cells. Cell Growth Differ., 8, 463-470.
52. Sheng, H., Shao, J., O'Mahony, C.A., Lamps, L., Albo, D., Isakson, P.C., Berger, D.H., Dubois, R.N. and Beauchamp, R.D. (1999) Transformation of intestinal epithelial cells by chronic TGF-β1 treatment results in downregulation of the type II TGF-β receptor and induction of cyclooxygenase-2. Oncogene, 18, 855-867.
53. Buckman, S.Y., Gresham, A., Hale, P., Hruza, G., Anast, J., Masferrer, J. and Pentland, A.P. (1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis, 19, 723-729.
54. Zhang, F., Subbaramaiah, K., Altorki, N. and Dannenberg, A.J. (1998) Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J. Biol. Chem., 273, 2424-2428.